MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
$293,100K
Intangible asset
amortization
$172,300K
Proceeds from maturity of
investments
$520,000K
Share-based compensation
$74,500K
Prepaid expenses and
other assets
-$51,900K
Acquisition accounting
inventory fair value...
$37,500K
Income taxes payable
$37,400K
Provision for losses on
accounts receivable and...
$14,200K
Other liabilities
$12,200K
Depreciation
$9,100K
Non-cash interest
expense
$4,700K
Other non-cash
transactions
-$3,900K
Proceeds from sale of
priority review voucher
$200,000K
Net cash provided by
operating activities
$408,200K
Net cash provided by
(used in) investing...
$123,100K
Canceled cashflow
$302,600K
Canceled cashflow
$596,900K
Net increase
(decrease) in cash and cash...
$452,400K
Canceled cashflow
$78,900K
Gain on sale of
priority review voucher
$122,800K
Inventories
$77,800K
Deferred tax benefit
-$66,200K
Accounts payable
-$21,400K
Accrued liabilities
-$7,900K
Accounts receivable
$6,500K
Acquisition of investments
$500,000K
Payments related to sale
of priority review...
$77,200K
Purchases of property,
plant and equipment
$19,700K
Proceeds from employee
equity incentive and...
$32,900K
Net cash used in
financing activities
-$78,500K
Effect of exchange
rates on cash and cash...
-$400K
Canceled cashflow
$32,900K
Payment of employee
withholding taxes related to...
$103,600K
Repayments of long-term
debt
$7,800K
Back
Back
Cash Flow
Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc (JAZZ)
source: myfinsight.com